Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Tanimoto

Showing results (41-50 of 353) with videos related to

Pageof 36
Sort By:
The New England Journal of Medicine|June 5, 2014
23andMe and the FDAKoichiro Yuji, Tetsuya Tanimoto, Yasuo Oshima
The New England Journal of Medicine|September 21, 2012
Review of novel therapeutics by three regulatory agenciesTetsuya Tanimoto, Eiji Kusumi, Shunsuke Ono
The New England Journal of Medicine|June 29, 2022
Rilzabrutinib in Immune ThrombocytopeniaJun Murakami, Yuki Senoo, Tetsuya Tanimoto
Lancet (London, England)|July 27, 2024
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trialKayo Harada, Akihiko Ozaki, Tetsuya Tanimoto
The New England Journal of Medicine|October 22, 2010
Second-generation BCR-ABL kinase inhibitors in CMLTetsuya Tanimoto, Akiko Hori, Masaharu Tsubokura
The New England Journal of Medicine|December 14, 2016
Inotuzumab Ozogamicin for Acute Lymphoblastic LeukemiaJinichi Mori, Kenji Tsuda, Tetsuya Tanimoto
The Lancet. Planetary Health|April 5, 2018
Smarter solutions for hotter times: what the Philippines can doAngeli Guadalupe, Akihiko Ozaki, Tetsuya Tanimoto
JAMA|April 11, 2018
Treatment Approaches for Malignant Pleural EffusionYukako Yagi, Kazuhiro Kosugi, Tetsuya Tanimoto
JAMA Oncology|June 8, 2018
Fiber Intake and Colorectal CancerTomohiro Kurokawa, Tetsuya Tanimoto, Giichiro Tsurita
The New England Journal of Medicine|March 16, 2012
SF3B1 in chronic lymphocytic leukemiaJinichi Mori, Yukie Takahashi, Tetsuya Tanimoto
Pageof 36

Showing results (41-50 of 353) with videos related to

Sort By:
Pageof 36
The New England Journal of Medicine|June 5, 2014
23andMe and the FDAKoichiro Yuji, Tetsuya Tanimoto, Yasuo Oshima
The New England Journal of Medicine|September 21, 2012
Review of novel therapeutics by three regulatory agenciesTetsuya Tanimoto, Eiji Kusumi, Shunsuke Ono
The New England Journal of Medicine|June 29, 2022
Rilzabrutinib in Immune ThrombocytopeniaJun Murakami, Yuki Senoo, Tetsuya Tanimoto
Lancet (London, England)|July 27, 2024
Sacituzumab govitecan for metastatic breast cancer: the TROPiCS-02 trialKayo Harada, Akihiko Ozaki, Tetsuya Tanimoto
The New England Journal of Medicine|October 22, 2010
Second-generation BCR-ABL kinase inhibitors in CMLTetsuya Tanimoto, Akiko Hori, Masaharu Tsubokura
The New England Journal of Medicine|December 14, 2016
Inotuzumab Ozogamicin for Acute Lymphoblastic LeukemiaJinichi Mori, Kenji Tsuda, Tetsuya Tanimoto
The Lancet. Planetary Health|April 5, 2018
Smarter solutions for hotter times: what the Philippines can doAngeli Guadalupe, Akihiko Ozaki, Tetsuya Tanimoto
JAMA|April 11, 2018
Treatment Approaches for Malignant Pleural EffusionYukako Yagi, Kazuhiro Kosugi, Tetsuya Tanimoto
JAMA Oncology|June 8, 2018
Fiber Intake and Colorectal CancerTomohiro Kurokawa, Tetsuya Tanimoto, Giichiro Tsurita
The New England Journal of Medicine|March 16, 2012
SF3B1 in chronic lymphocytic leukemiaJinichi Mori, Yukie Takahashi, Tetsuya Tanimoto
Pageof 36